Tops & Flops Stocks
| Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Tandem Diabetes Care Inc | 24.660% | 25.332% | 33.548% | 14.934% | 49.496% | -45.588% | - |
| LivaNova plc | 10.680% | 11.765% | 14.919% | 35.071% | 21.795% | -18.571% | -12.308% |
| Premier Inc. | 7.240% | - | - | - | - | - | - |
| Canopy Growth Corp | 7.100% | - | - | - | - | - | - |
| Ironwood Pharmaceuticals | 6.210% | 4.054% | 1.987% | -18.085% | -24.510% | -15.847% | - |
| PTC Therapeutics Inc. | 4.030% | 33.621% | 20.155% | -36.735% | 23.016% | -6.061% | -5.025% |
| Hutchison China MediTech Ltd ADR | 3.450% | 5.780% | 17.308% | 15.823% | 15.823% | - | - |
| Agios Pharmaceuticals Inc. | 3.380% | 3.378% | 18.605% | 47.115% | 48.544% | -33.159% | -37.056% |
| Halozyme Therapeutics Inc. | 3.000% | 1.697% | 0.054% | 26.662% | 9.749% | -9.035% | - |
| Amarin Corp. ADR | 2.340% | 3.067% | -13.846% | -31.707% | 3.067% | -79.612% | -94.764% |
| Xencor Inc. | 2.230% | - | -6.030% | -25.794% | -9.223% | -46.418% | - |
| Bio-Techne Corp. | 2.130% | 23.077% | 12.500% | -1.370% | 1.408% | - | - |
| Novocure Ltd | 2.120% | 16.088% | 3.044% | -77.020% | -3.958% | -91.837% | - |
| Alnylam Pharmace. | 1.930% | 5.751% | 0.963% | -22.198% | -20.000% | 26.091% | 104.358% |
| Acadia Pharmaceuticals | 1.450% | - | -7.081% | -18.672% | -45.018% | -6.998% | -32.549% |
| Neogenomicsinc. | 1.450% | 12.598% | 3.623% | 7.519% | -8.333% | -64.882% | - |
| Merit Medical Systems | 1.440% | 2.174% | 5.224% | -3.425% | 3.676% | 34.286% | 39.742% |
| Arrowhead Pharmaceuticals Inc. | 1.290% | 9.869% | -7.117% | -37.558% | -19.354% | -62.475% | 39.805% |
| Bruker Corp. | 1.220% | -13.961% | -22.505% | -10.849% | -2.135% | - | - |
| Medpace Holdings Inc | 1.180% | 0.523% | -0.164% | 96.344% | 29.964% | 160.857% | - |
| Viatris Inc. | 1.060% | 1.388% | -1.261% | 32.479% | 12.387% | -2.055% | -56.160% |
| Sartorius AG VZO | 1.030% | -1.756% | -18.550% | -21.830% | -13.984% | -39.147% | 72.031% |
| Spark Therapeutics | 1.030% | - | - | - | - | - | - |